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Abstract
With the depenalization of professional conduct of the physician in case of adherence to the guide-
lines proposed by L. 189/2012 the discussion on the quality of the available guidelines in the litera-
ture has led the authors to a review with particular regard to stakeholder involvement in the elabo-
ration process. Evident critical points arise in the accessible studies that have used as an assessment 
tool a scientifically validated questionnaire (Appraisal of Guidelines for Research and Evaluation 
– AGREE). As a result the solution of the legislature, although useful to contain the phenomenon of 
defensive medicine, may be useless and ineffective in criminal cases where fundamental and abso-
lute rights, as the right to life and health of patients, are involved.
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Introduction
After the L. 189/2012 in Italy the debate on the topic of professional responsibility has increased and the 
attention of health policy has once again raised the issue of the definition of serious fault.
In order to put a stop to the phenomenon of defensive medicine and considerable increases in health 
care spending, the legislature depenalized the offense in the case of adherence to guidelines, without 
any reference to the quality of the recommendations proposed as best scientific evidence.
In particular, the stakeholder involvement is one of the most important aspects in the process of formu‑
lation of recommendations that could go also to influence their operational applicability.
And, therefore, serious doubts may arise in the evaluation of professional conduct also in case of adherence.
The authors propose a review of the literature on previous experience of assessing the quality of guide‑
lines through the use of a standardized and validated scientifically tool.
Material and method
The used instrument in the selected articles is Appraisal of Guidelines for Research and Evaluation 
(AGREE), in both versions I and II, developed by the AGREE Next Steps Consortium and available on 
www.agreetrust.org.
This instrument consists of 23 items grouped into six areas: objectives and scope, stakeholder involve‑
ment, methodological rigor, clarity, applicability and editorial independence.
The items related to the domain “stakeholder involvement” are shown in Table I with clear removal of 
a single question in the new version of the AGREE II.
Each item is rated on a seven‑point Likert scale from “strongly disagree” to “strongly agree” (1‑7 re‑
spectively) [1].
The study predicts that the guidelines on a specific subject are submitted to the evaluation of more ex‑
perts chosen on the basis of the interests in the management of type of pathology and patient. For each 
of the six dimensions of the instrument a score is calculated by adding together all the scores of each 
evaluator for the items that compose the area. 
The obtained score is standardized as a percent‑
age of the maximum possible score for that area 
applying the following form:
OS = Obtained Score;  
MinPS = Minimum Possible score;  
MaxPS = Maximum Possible score
In research of articles on Medline were used 
title’s keywords “guidelines” and “AGREE”. 
Forty‑three results have been obtained, but re‑
moving the studies that did not provide for the 
use of the AGREE instrument or comments / 
letters to the editor or those that lacked one of 
the parameters considered (or just average, or 
median, or just only range) or was not possible 
to derive it, there are only eleven.
AGREE 4 The guideline development group includes 
individuals from all the relevant professional 
groups
5 The patients’ views and preferences have 
been sought
6 The target users of the guideline are clearly 
defined
7 The guideline has been piloted among end 
users
AGREE II 4 The guideline development group includes 
individuals from all
relevant professional groups
5 The views and preferences of the target 
population (patients, public, etc.)
have been sought
6 The target users of the guideline are clearly 
defined
Table I. Items of area “stakeholder 
involvement” in AGREE and in AGREE II
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Results
The articles selected are shown in Table II.
In the study of Lytras et al. [2] six expert evaluators examined seven guidelines on occupational asthma 
choices on the Medline database: two guidelines remained much below the 50%, EAACI [3] 39% and 
EAACI PEF [4] 36%.
In the systematic review [5] of published guidelines on the treatment of acne vulgaris from July 2002 to 
July 2012 in English, French, German and Spanish, three expert evaluators have worked on six selected 
articles and in this case 3/6 have reported values  <50%: Strauss et al. [6] (27,7%), AFSSAPS [7] (31,4%) 
and Orozco et al. [8] (14,8%).
Sabharwal et al. [9] have studied the quality of cardiac clinical practice guidelines published in seven 
cardiac cardiovascular journals between January 2001 and May 2011 (one hundred and one!), and, 
examined by two researchers, the minimum value achieved 39.9%.
In the analysis of thirteen guidelines in English on genetic syndromes that confer susceptibility to 
breast cancer [10], selected until October 2010 and reviewed by three reviewers, 6/13 <50% with the 
recommendations of the University of Michigan even 8.3% [11].
In the study by Polus et al. [12] on the quality of four WHO guidelines on maternal and child health 
published between 2007 and 2011 can be appreciated a chronological evolution from 32% of the P‑PPH 
(2007) [13] to 86% of PE/E (2011) [14].
In the work of Don‑Wauchope et al. [15] the AGREE II was applied by two evaluators on eleven guide‑
lines for laboratory medicine available until December 2011. Nearly half (5/11) less than 50%, with the 
lowest result 11% [16].
In the study by Van Den Berg et al. [17] on the methodological quality of twelve international clinical 
guidelines for the management of malnutrition in adult cancer patients and reviewed by three review‑
ers, 8/12 ≤ 50% with Bozzetti et al. [18] and Braga et al. [19] 17%.
Burda et al. [20] with five independent evaluators have reviewed eleven clinical practice guidelines on 
the frequency of screening mammography in asymptomatic women (40‑49 years) and published from 
2005 to 2010, and 9/11 <50% with Michigan Quality Improvement Consortium 0% [21] and Society of 
Breast Imaging 8% [22].
Study Mean Median Range
Lytras, 2013 [2] 53,14 55 36‑74
Sanclemente, 2013 [5] 46,23 43,45 14,8‑81,4
Sabharwal, 2013 [9] 58,5 58,3 39,9‑80,6
Simone, 2012 [10] 50,84 50 8,3‑75
Polus, 2012 [12] 59,5 60 32‑86
Don‑Wauchope, 2012 [15] 50,18 50 11‑100
van den Berg, 2012 [17] 42,83 36 17‑83
Burda, 2011 [20] 26 22 0‑70
Lo Vecchio, 2011 [23] 39,8 35 14‑88,9
Manchikanti, 2008 [25] 6,25 6,25 6,25‑6,25
Hulshof, 2007 [28] 67 65,6 58,3‑81,3
Table II. Selected articles
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In the study by Lo Vecchio et al. [23] on nine guidelines in English about the management of acute 
gastroenteritis in children examined from six auditors 7/9 <50%, with 14% of Sandhu et al. [24].
The evaluation of the chapters of ACOEM guidelines [25] on the management of low back pain [26] 
and chronic pain [27] score was not different from 6.25%.
And finally, only in the study by Hulshof and Hoenen [28] on six guidelines of Netherlands Society of 
Occupational Medicine examined by twenty experts 6/6> 50%.
Discussion
Stakeholders are all subjects who have an interest in the purpose / objective of the recommendations, 
such as health professionals, patients, public and private research funding, managers, entrepreneurs 
and producers.
The involvement of these subjects is justified by many reasons, in particular for transparency, but in 
some cases a stakeholder engagement inclusive, fair and appropriate can be difficult [29].
There have been experiences that have analyzed the stakeholder engagement only in the development 
and evaluation of the recommendations, neglecting the next and operational phase, that is sharing in 
the decision making process [30,31], maybe because they are not understood [32,33] or because the 
heterogeneity of “users” and their degree of involvement in decision making [34].
However it has been shown that the adoption of shared decision making and the involvement in the 
implementation process of the disclosure of scientific evidence [35] has had important and significant 
impact in efficiency [36], as was the case for infection control [37].
The involvement of a part / interest can lead, for example, to a simplification of complex innovations 
[32]. And also, like the involvement of the management can help to mobilize resources, so that patients, 
defined as “temporary members” of health care organizations, contributes to faster adoption of the 
recommendation [38,39].
Health policies, both U.S.A. than UK, explicitly promote stakeholder engagement considering a means 
to achieve the aim of reducing costs [40] and improving quality, increasing satisfaction [41]. These poli‑
cies define user as a exacting subject and buyer of a service, with the responsibility to contribute to the 
common good through active participation [42].
The reasons for failure in stakeholder engagement, as can be appreciated in most of the articles exam‑
ined in this paper must be sought in the scarce organization and competence, financial difficulties and 
time [43].
Resulting defective in this aspect, it is also conditioned the implementation of the recommendation 
and, therefore, also the subsequent use in the medico legal evaluation of professional responsibility 
where the respect for the prevalent right to the life or health of single patient is more important than 
health care cost containment.
Conclusion
The legislature, decriminalizing the profession‑
al conduct only on the basis of the adherence to 
guidelines, neglecting the consideration of the 
quality of the guidelines currently available in 
the literature, has strongly influenced the effec‑
tiveness of this instrument of health policy.
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